| A Study to Evaluate the Effect of XY0206 on the QTc Interval in Chinese Healthy Participants (NCT07162116) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2025-07-06 |
| A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke (NCT06755944) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2024-12-15 |
| A Study on the Substance Balance of [14C]XY0206 in Healthy Adult Chinese Men (NCT06823232) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2024-11-06 |
| A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours (NCT06027346) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2023-07-17 |
| A Study of XY0206 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory AML With FLT3-ITD-Mutation (ALIVE) (NCT05876832) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2023-06-15 |
| A Study of XY03-EA Tablets in the Treatment of Acute Ischemic Stroke (NCT05515393) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2022-09-24 |
| A Phase Ⅲ Clinical Study Trial of Felbinac Trometamol Injection in China (NCT04526132) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2021-04-25 |
| Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets (NCT04693039) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2021-02-23 |
| A Study of XY0206 Tablets in Patients With Relapsed / Refractory Acute Myeloid Leukemia (NCT04471064) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2020-09-15 |
| A Phase Ⅱ Clinical Study Trial of Felbinac Trometamol Injection in China (NCT03872830) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2019-03-27 |
| A Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours (NCT03658070) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2018-12-19 |
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China (NCT03617510) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2018-07-10 |